{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05948956",
            "orgStudyIdInfo": {
                "id": "HUM00232413"
            },
            "organization": {
                "fullName": "University of Michigan",
                "class": "OTHER"
            },
            "briefTitle": "Effects of Exercise Training and Ketone Ester on Muscle Strength and Cardiovascular Response in Parkinson's Disease",
            "officialTitle": "Effects of Combined Exercise Training and Ketone Ester on Muscle Strength and Cardiovascular Response in Parkinson's Disease",
            "acronym": "CYCLE",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "effects-of-exercise-training-and-ketone-ester-on-muscle-strength-and-cardiovascular-response-in-parkinson-s-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-26",
            "studyFirstSubmitQcDate": "2023-07-12",
            "studyFirstPostDateStruct": {
                "date": "2023-07-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Chatkaew Pongmala",
                "investigatorTitle": "Research Investigator",
                "investigatorAffiliation": "University of Michigan"
            },
            "leadSponsor": {
                "name": "University of Michigan",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main purpose of this study is to assess changes in exercise capacity in people with Parkinson's disease before and after an exercise training program with ketone ester supplementation."
        },
        "conditionsModule": {
            "conditions": [
                "Parkinson Disease"
            ],
            "keywords": [
                "Exercise",
                "Ketone Ester",
                "Keto"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 16,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Ketone Ester Beverage & Exercise",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will consume ketone ester (KE) beverage, consisting of 2 scoops (=25 g C8-KE) of Juvenescence Cognitive Switch \u2122 and electrolyte solution diluted in water, before each of 5 1-hour sessions of aerobic exercise.",
                    "interventionNames": [
                        "Dietary Supplement: Ketone Ester Beverage",
                        "Behavioral: Cycling Intervention"
                    ]
                },
                {
                    "label": "Electrolyte Beverage & Exercise",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will consume placebo electrolyte (EL) beverage, consisting of an electrolyte solution diluted in water, before each of 5 1-hour sessions of aerobic exercise",
                    "interventionNames": [
                        "Dietary Supplement: Electrolyte Beverage",
                        "Behavioral: Cycling Intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Ketone Ester Beverage",
                    "description": "Participants will consume ketone ester (KE) beverage, consisting of 2 scoops (=25 g C8-KE) of Juvenescence Cognitive Switch \u2122 and electrolyte solution diluted in water, before each of 5 1-hour sessions of aerobic exercise.",
                    "armGroupLabels": [
                        "Ketone Ester Beverage & Exercise"
                    ],
                    "otherNames": [
                        "Juvenescence Cognitive Switch\u2122"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Electrolyte Beverage",
                    "description": "Participants will consume an electrolyte solution diluted in water, before each of 5 1-hour sessions of aerobic exercise.",
                    "armGroupLabels": [
                        "Electrolyte Beverage & Exercise"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Cycling Intervention",
                    "description": "Five 1-hour sessions of cycling on the ergometer over a 2-week period. Sessions will consist of a 10 min warm up followed by 8 intervals consisting of 3 min \"fast\" cycling at 80-90 rpm followed by 2 min of \"slow\" cycling at \u226460rpm, followed by a 10-minute cool-down.",
                    "armGroupLabels": [
                        "Electrolyte Beverage & Exercise",
                        "Ketone Ester Beverage & Exercise"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in duration of 80 rpm endurance test",
                    "description": "Participants will cycle at their personalized fixed wattage at 80 rpm until failure, defined as the point at which the participant could not sustain a cadence of \\>70 rpm for a cumulative total of 20 s, or until voluntarily choosing to end the test. Change in duration will be calculated by subtracting the baseline duration from duration at follow-up. Greater duration indicates better endurance.",
                    "timeFrame": "After approximately 2-weeks of intervention"
                },
                {
                    "measure": "Change in isometric quadricep muscle strength",
                    "description": "Participants will sit on an ergometer with their knee secured at a 90-degree angle. Participants will be instructed to perform a maximal effort static knee extension against the resistance of the ergometer for up to 5 trials. Isometric quadricep muscle strength will be measured as the mean torque in Newtons exerted on the ergometer by the participant across all trials. Change in strength will be calculated by subtracting the mean torque at baseline from the mean torque at follow up. Greater torque indicates greater isometric quadricep strength.",
                    "timeFrame": "After approximately 2-weeks of intervention"
                },
                {
                    "measure": "Change in oxygen uptake (VO2 max)",
                    "description": "VO2 max (defined as volume of oxygen consumed in mL divided by body weight in kg per minute) will be measured during a controlled cycling session on a stationary bike. Participants will begin at a cadence of 80 rpm at 50 watts for 4 minutes. Thereafter, wattage will increase by 10 watts every 2 minutes until the participant voluntarily ends the session or is no longer able to sustain a cadence of \\>70 rpm. Participants will wear a face mask that measures their oxygen intake during the session. Change in VO2 max will be calculated by subtracting the baseline VO2 max from VO2 max at follow-up. Greater VO2 max indicates better cardiorespiratory fitness.",
                    "timeFrame": "After approximately 2-weeks of intervention"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of Parkinson's Disease\n\nExclusion Criteria:\n\n* Any recent changes in EKG, history of myocardial infarction or other cardiac event or other cardiac contraindications to exercise\n* Inability to use a step, stand, walk, or use a stationary cycle ergometer\n* History of symptoms in exercise that preclude safe and comfortable participation, such as dizziness and lightheadedness, orthostasis, severe symptomatic leg or back musculoskeletal pain, painful neuropathy, significant ankle edema or medication side effects\n* History of symptomatic cardiovascular or pulmonary disease interfering with exercise\n* History of active rheumatoid arthritis\n* History of uncontrolled chronic pain syndrome\n* Any other history of medical or psychiatric comorbidity precluding safe participation in the project\n* Poorly controlled diabetes\n* Pregnancy or breastfeeding\n* Clinically significant dementia\n* Any contraindications to MRI (metal implants, severe claustrophobia, inability to lie still for 1 hour, etc.)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "45 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Austin Luker, BS",
                    "role": "CONTACT",
                    "phone": "734-936-0111",
                    "email": "aluker@med.umich.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Chatkaew Pongmala, PhD",
                    "affiliation": "University of Michigan",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Domino's Farms",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48105",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robert Vangel, BSc",
                            "role": "CONTACT",
                            "phone": "734-936-1168",
                            "email": "rvangel@med.umich.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010300",
                    "term": "Parkinson Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020734",
                    "term": "Parkinsonian Disorders"
                },
                {
                    "id": "D000001480",
                    "term": "Basal Ganglia Diseases"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000080874",
                    "term": "Synucleinopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13213",
                    "name": "Parkinson Disease",
                    "asFound": "Parkinson's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22494",
                    "name": "Parkinsonian Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M25603",
                    "name": "Ganglion Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M16358",
                    "name": "Synovial Cyst",
                    "relevance": "LOW"
                },
                {
                    "id": "M4774",
                    "name": "Basal Ganglia Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M2217",
                    "name": "Synucleinopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}